AF488 Anti-Human CD11a Antibody[R7-1]

Introducing the AF488 Anti-Human CD11A Antibody [R7-1], a highly advanced and meticulously developed product designed to cater to the specific needs of the scientific community. This antibody, labeled with AF488, offers exceptional specificity and sensitivity in detecting the CD11A antigen in human samples.

The AF488 Anti-Human CD11A Antibody [R7-1] has been meticulously engineered using cutting-edge technology and rigorous quality control measures to ensure optimal performance and reliability. Its superior binding affinity to the CD11A antigen enables accurate and precise identification, making it an invaluable tool for various research applications.

This antibody is manufactured with utmost precision, adhering to the highest industry standards. Its AF488 labeling provides enhanced fluorescence, allowing for easy visualization and analysis of CD11A expression in various experimental settings. The AF488 Anti-Human CD11A Antibody [R7-1] is compatible with a wide range of techniques, including flow cytometry, immunofluorescence, and immunohistochemistry, making it a versatile choice for diverse experimental requirements.

Furthermore, this antibody exhibits exceptional specificity, ensuring minimal cross-reactivity with non-target antigens. Its high sensitivity enables the detection of even low levels of CD11A expression, facilitating accurate quantification and analysis. The AF488 Anti-Human CD11A Antibody [R7-1] is designed to provide reliable and reproducible results, enabling researchers to confidently advance their scientific investigations.

In summary, the AF488 Anti-Human CD11A Antibody [R7-1] is a state-of-the-art product that combines advanced technology, meticulous manufacturing processes, and exceptional performance. Its superior specificity, sensitivity, and compatibility with various techniques make it an indispensable tool for researchers in the field. Choose the AF488 Anti-Human CD11A Antibody [R7-1] to elevate your research to new heights and unlock the potential of CD11A analysis.